chrisvoncsefalvay/vaers-outcomes huggingface dataset:
COVID 19; COVID 19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 75-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 18Jan2021 as dose 1, single (Lot number: EL3247), in left arm and on 06Feb2021 as dose 2, single (Lot number: EM9810) at the age of 73 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 04Nov2021 as dose 3 (booster), single (Lot number: 026D21A), in left arm and on 20May2022 as dose 4 (booster), single (Lot number: 002M21A), in left arm for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: SIMVASTATIN. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "COVID 19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Indication: Treatment of COVID-19; (17Sep2022) Positive, notes: Tested on 5th day after stopping paxolvid and tested very clear positive. Therapeutic measures were taken as a result of vaccination failure, covid-19.
It was reported a female patient was given Imovax Rabies vaccine on 14-Dec-2000. Reportedly, sometime after receiving vaccination, the patient experienced "numbness in right arm occurring mostly in right hand". From additional information received on 20-Feb-2001, it was reported, "7-Dec-2000 patient noticed a 'burning sensation' on first injection with Rabies. Did not mention to RN. That night experienced numbness and tingling in right hand. Problem reoccurred intermittently, only at night. Approximately 5-Jan-2001 became 'severe', lost ability to grip, had problem day and night for approximately 2 days. Informed supervisor 6-Jan-2001. 9-Jan-2001 numbness subsided somewhat. Client reports has been lessening. 14-Dec-2000. Patient received second rabies pre-exposure immunization. Patient was directly asked prior to vaccine administration if she had experienced any problems or reactions with the first vaccination. Client denied any problems or reactions at this time. She did not inform the nurse administering the second vaccine of any problem with numbness and/or tingling in right arm. Patient was referred to a local infectious disease expert who agreed that it was not a reaction to the vaccine material itself, but probably due to inadvertent injections of the material into the fascial resulting in pain and subsequent local neuralgia. The third dose was not given and is being deferred pending the results of rabies titer is ascertained.
Excessive bleeding, needing to change pad every 1-2 hours for 8 days.  Very unusual because I am in peri-menopause.
he developed bloody diarrhea 2 days after vaccine Meningococcal 10/3/06 with ulcerative colitis. 10/27/06 Received medical records from PCP which reveal patient seen 9/9/06 for MCV4 vax.  Seen next 9/22 w/BRB in stool that AM.  C/O diarrhea 3x/day for 1-2 weeks self treating with yogurt & OTC antidiarrheal meds.  No fever.  Continued to have blood & mucous in loose stools 3x/day & was referred to GI specialist for colonoscopy & biopsy. 1/2/07 Received medical records from GI specialist which reveal patient had stool cultures for Shiga toxins & yersinia done 10/4 which were neg.  Colonoscopy done 10/6/06 for rectal bleeding.  It was felt at time of scope that it could be colitis or possibly ulcerative colitis.  Multiple biopsies were taken at that time.  Path report returned dx of acute & chronic inflammation, acute cryptitis, crypt abscesses, surface ulceration & cryt distortion consistent with inflammatory bowel disease throughout the transverse, descending & sigmoid colon & rectum.  Started on Asacol & improved significantly with no further abdominal pain, rectal bleeding or diarrhea.
Fever to 102 degrees F; This is a spontaneous report from a contactable physician (patient himself). A 63-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at site of left arm at 12:45 on 29Dec2020 at single dose for COVID-19 immunization. Medical history reported as none. There were no concomitant medications. The patient had fever to 102 degrees F at 15:00 on 01Jan2021. The patient had Nasal Swabars for COVID test with negative result on 04Jan2021. No treatment received for the adverse event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Facility where the most recent COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. No list of any other medications the patient received within 2 weeks of vaccination. Adverse event resulted in doctor or other healthcare professional office/clinic visit. The case was identified as non-serious by reporter. The outcome of event was recovered in Jan2021.  Information on the lot/batch number has been requested.
lightheadedness; feeling drained/Fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 18Nov2021 18:00 (Lot number: 30155BA) at the age of 39 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Allergy" (unspecified if ongoing), notes: Repeating Node Relevant past drug history: , Name of Drug as Reported: no, Reaction: Allergy , . Concomitant medication(s) included: FLU taken for immunisation. Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: 3248, Location of injection: Arm Left, Vaccine Administration Time: 13:00 PM), administration date: 23Mar2021, when the patient was 39 years old, for Covid-19 immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3248, Location of injection: Arm Left, Vaccine Administration Time: 13:00 PM), administration date: 02Mar2021, when the patient was 39 years old, for Covid-19 immunization. The following information was reported: DIZZINESS (non-serious) with onset 19Nov2021 06:00, outcome "not recovered", described as "lightheadedness"; FATIGUE (non-serious) with onset 19Nov2021 06:00, outcome "not recovered", described as "feeling drained/Fatigue". Therapeutic measures were not taken as a result of dizziness, fatigue.  Additional information: Other medications the patient received within 2 weeks of vaccination included Flu Shot Quad. Facility where the most recent COVID-19 vaccine was administered: Pharmacy or Drug Store. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. No treatment was received.  Follow-up attempts are completed. No further information is expected.
recieved Moderna COVID-19 Vaccine while pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (recieved Moderna COVID-19 Vaccine while pregnant) in a 33-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 13-Sep-2021. On 02-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (recieved Moderna COVID-19 Vaccine while pregnant). On 02-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (recieved Moderna COVID-19 Vaccine while pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided by the reporter.  No treatment information was provided by the reporter.
-INFANRIX administered in right thigh on 5/3/2010. -Developed rough/erythema which maculopapular eruption at injection site over most of right thigh-not entirely circumferential-treated with TYLENOL and ice.
10/12/18 when contacted because patient had not gotten second dose, caregiver reported arm was swollen and was not going to get another dose. No time course details were reported.  4/29/19 caregiver declined second dose during exam; reported rash after getting first dose. No time course details were reported. No evidence of any care for this response. No reports of symptom to clinic until several months later.
felt tired; This spontaneous case was reported by a patient and describes the occurrence of FATIGUE (felt tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 022C21A, 001A21A and 039K20A) for COVID-19 prophylaxis.     Concurrent medical conditions included Seasonal allergy (seasonal allergies), Seafood allergy (shrimp) and Penicillin allergy.   On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (felt tired). At the time of the report, FATIGUE (felt tired) outcome was unknown.            No concomitant medications information was reported. No treatment medications were provided.   This case was linked to MOD-2022-616435 (Patient Link).
Information was received from a pharmacy technician who reported that RECOMBIVAX HB was improperly stored and exposed to 71F for unknown timeframes prior to the birth of unspecified patients. No adverse effects were reported. No further information was provided. Additional information has been requested.
Developed a papule on 06/22/2006, since then papules increased in number from abdomen to back. Also had ear infection and was prescribed Amoxicillin (400mg).
Eating almost nothing, today ate a salty cracker and a banana; Abdominal Cramp; Malaise; bad Head ache; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (Eating almost nothing, today ate a salty cracker and a banana), ABDOMINAL PAIN (Abdominal Cramp), MALAISE (Malaise) and HEADACHE (bad Head ache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 010M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (Eating almost nothing, today ate a salty cracker and a banana), ABDOMINAL PAIN (Abdominal Cramp), MALAISE (Malaise) and HEADACHE (bad Head ache). At the time of the report, DECREASED APPETITE (Eating almost nothing, today ate a salty cracker and a banana), ABDOMINAL PAIN (Abdominal Cramp), MALAISE (Malaise) and HEADACHE (bad Head ache) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Concomitant drug was not reported. Treatment included IVD Medication.   This case was linked to MOD-2021-032429 (Patient Link).   Reporter did not allow further contact
pt devel fever to 102.7 & inconsolable x 48 hr; screaming up all noc x 2 noc; PE nl only slept 10 mins @ a time;
Lymph node on my collarbone (the left side). skin rash over different parts of my body (right hand +right leg).
Patient noted standard arm soreness and some fatigue within 24 hours of vaccination, which did not concern her in any way, but specifically reported a large bruise forming about 48 hours after (she noticed it Saturday morning following vaccination on Thursday morning). She reported the bruise was about 3 inches by 1.5 inches, but that she did not have any unusual pain, nor any limitations to her mobility.
One week after receiving the vaccine: Swelling, redness area, warmth, itchiness. Extensive arm area. Panadol, ice. Today Sunday 2/21, the swelling has improved, but is still red and warm, I keep applying ice. (during the first 3 days of being vaccinated, only had light symptoms: small red area.) I would like to know if this is normal (The number of days with these symptoms). Thanks.
LIGHTHEADED, POST VACCINE 10 MINS.  HAS FAINTED BEFORE AS A CHILD MIXTURE OF NERVES AND IT AS WARM INSIDE TENT
Patient described waking up with difficulty hearing out of her right ear. Patient has hearing aids and states they could not hear chime when turned on (not sure if hearing aid is dead or from vaccine). Told patient would be wise to inform MD in case its vaccine or something else happening.
Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013120A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced PAIN (Pain). At the time of the report, PAIN (Pain) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication details were not reporter by the reporter. Treatment details was not reported by the reporter.   Reporter did not allow further contact
Died from heart inflammation two months after receiving his Pfizer Covid-19 vaccine; This is a spontaneous report from a contactable consumer. A male patient (Reporter's uncle) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (Batch/Lot Number: Unknown) as DOSE NUMBER UNKNOWN, SINGLE for covid-19 immunisation. He had died from heart inflammation two months after receiving his Pfizer COVID-19 vaccine. It is unknown if autopsy was done. Outcome of the event was fatal.  Reporter implied that the two were related.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: heart inflammation
Fever of 100.8; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 100.8) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Oct-2021, the patient experienced PYREXIA (Fever of 100.8). At the time of the report, PYREXIA (Fever of 100.8) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 28-Oct-2021, Body temperature: 100.8 (High) fever of 100.8..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported. No treatment medications were reported.   Reporter did not allow further contact
Within 3 days I began developing chest pains  It would be spread through my neck, jaw, upper back Reported to ED on the 5th day as all pains intensified  Blood pressure was normal  Heart rate was not 119 ECG showed sinus tachycardia  Was sent home with Diazepam  Next evening the chest pains continued as did the sinus tachycardia now at 144 Received antenolol - X-ray was done no abnormalities  I came back to the ED the next day after feeling extreme fatigue and bad chest pains  Echo was done normal  Was hospitalised over night for observation  Chest pains subsided now But tingling, numbness, heaviness, weakness in right arm has begun, my left arm slightly  Reported to clinic today for extreme dizziness also  Prescribed stemetil.
Patient stated that his arm was swollen after the shot and it never went away. He subsequently got an MRI and it showed a full thickness rotater cuff tear. He is now talking to a surgeon about surgery.
Tested positive for covid; Tested positive for covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 17 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date Nov2021 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "t1 diabets" (unspecified if ongoing); "shellfish" (unspecified if ongoing); "penicillin" (unspecified if ongoing). Concomitant medication(s) included: INSULIN. Past drug history included: Augmentin, reaction(s): "Allergy". Vaccination history included: Bnt162b2 (Dose number=2, Product=COVID 19, Brand=Pfizer, Lot unknown=True, Lot unknown reason=Other, Lot unknown reason other=dont have card, Administrator route=Intra muscular, Administration date=Mar2021, Vaccine location=Left arm), administration date: 2021, for Covid-19 immunization; Bnt162b2 (Dose number=1, Product=COVID 19, Brand=Pfizer, Lot unknown=True, Lot unknown reason=Other, Lot unknown reason other=dont have card, Administrator route=Intra muscular, Administration date= Apr2021, Vaccine location=Left arm), administration date: 2021, for Covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 01Mar2022, outcome "unknown" and all described as "Tested positive for covid". The patient underwent the following laboratory tests and procedures: sars-cov-1 test: (01Mar2022) positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of drug ineffective, covid-19.  Clinical course- Facility where the most recent COVID-19 vaccine was administered was Public Health/Military facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was insulin medications the patient received within 2 weeks of vaccination. Since the vaccination the patient tested for COVID-19. The patient did not received any treatment.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
no adverse effects; expired dose of VARIVAX was administered to a patient; This spontaneous report as received from a registered nurse referring to a patient of unknown age and gender. No information was provided regarding the patient's medical history, concurrent conditions or concomitant medications.  On 14-JUN-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous (dosage schedule and anatomical location were not reported), lot # N017394 with expiration date on 07-JUN-2019, indicated for prophylaxis (expired product administered). No adverse event was reported.
Red itchy rash on right arm extending from injection site down to elbow. Rash is also on left arm same location less irritated. Rash spread to both hips, down to thighs above knees.
J&J vaccine use for COVID-19 under Emergency Use Authorization (EUA): Dural venous sinus thrombosis (DVST), Thrombocytopenia, Hematology was consulted and diagnosed her with VIIT..
Narrative:  States she developed a low grade fever, some nausea, body aches, and fatigue. States symptoms improved, "but now I am concerned about the injection site." Patient states injection site on her L arm is red (measures approximately 2 inches x 4 inches), "with a strange rash, and other red areas around it, hard to explain." States redness has worsened overnight; other symptoms are gone. No lumps or drainage at injection site.
patient received injection and started not feeling well. Hisface turned deep red and he planked his body (possible anxiety attack). Patient never lost consciousness but then he started shaking and sweating heavily. Blood pressure was 121/73 pulse 70 and breathing was normal.  Store manager called 911 and paramedics arrived -- checked vitals and patient stated he felt better and did not want to go to the hospital.
Patient currently inpatient at (5) days. Pt is a 77 y.o. male with past medical history significant for paroxysmal AFib on Coumadin, CVA, hypertension, type 2 diabetes who presents to the emergency department with generalized weakness and dyspnea on exertion.   Patient tested positive for COVID-19 on a home test yesterday.  He developed symptoms 2 days ago.  He is fully vaccinated with his last vaccine in February 2021 and has not received a booster.  Patient developed progressive generalized weakness, dyspnea on exertion, dry cough, wheezing, and malaise over the last 48 hours.  They called his PCP today who sent him into the emergency department.  He reports poor appetite.  No nausea, vomiting, diarrhea.  His wife is currently admitted.   In the emergency department patient was hypoxic and placed on 6 L nasal cannula.  Was weaned to 4 L. Chest x-ray shows COVID pneumonia.  He was given Decadron.   COVID-19 pneumonia Acute hypoxic respiratory failure Vaccinated, last vaccination February 2021 Positive home test 11/27, symptom onset 11/26 Chest x-ray shows COVID pneumonia Currently on 4 L nasal cannula Decadron PO Remdesivir IV Albuterol q6hr for wheezing mucinex BID Acapella, IS Prone as able Daily CBC, CMP, CRP, Ddimer   AKI on CKD stage 3 BUN 28, creatinine 1.48 with baseline creatinine 1.2 Hold ACE-I Normal saline 100 mL/hr for 1 L then Hep-Lock Trend BMP in a.m.   Recent left eye cataract surgery Left cataract surgery 1 and half weeks ago Family is unsure if he needs prednisolone and trimethoprim polymyxin B eyedrops still, will check bottles when they go home and call us with dosing instructions   Paroxysmal atrial fibrillation Continue atenolol On Coumadin with subtherapeutic INR 1.2 Pharmacy consult to manage Coumadin Daily INR Will place on Lovenox 40 mg subQ daily while INR is subtherapeutic for DVT prophylaxis   Generalized weakness PT/OT   History of CVA  Mild residual cognitive deficits Continue statin, Coumadin per above   Essential hypertension Hold ACE-inhibitor Continue amlodipine, atenolol   Diabetes mellitus type 2, insulin dependent Hold metformin, not on sliding scale insulin at home Decrease home Lantus from 60 units to 45 units and continue moderate dose sliding scale corrective   Mood disorder Paxil   Diet: General  VTE ppx: lovenox subQ daily while INR is subtherapeutic Code status:  Full code per patient and son at bedside.  Patient's sons share medical power of attorney for patient.   Disposition: admitted as inpatient for COVID pneumonia. Anticipated LOS > 2 midnights.
36 hours after injection I developed gross swelling and lymphadenopathy of the left upper limb and chest wall. This was painful, requiring regular Tylenol and ibuprofen. I have pictures and videos demonstrating the extent of the swelling. My body weight was elevated by 3 lbs due to the swelling. It took 6 days to begin resolving and was visible to an untrained eye even while fully clothed. I have previously had covid and am almost certainly immune having treated over 100 covid positive patients.0
Several hours after she received the flu vaccine, the pts eyes started "gooping up" & her breathing became restricted. The patient also complained of aches. The next day her aches were gone & her breathing returned to normal. Her eye were swollen, but clear. She spoke with her MD, who thought it was an AE from the vaccine.
Left shoulder pain, decreased range of motion, stiffness, tenderness. Also whole left arm goes numb nightly
Information has been received from a physician concerning a friend of a friend's daughter a 17 year old female who was vaccinated with a dose of GARDASIL. The patient was experiencing fertility problem after administration of GARDASIL. No further information is available.